Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04623775 |
|---|---|
| Brief Title: | A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC) |
| First Submitted : | November 5, 2020 |
| First Submitted that Met QC Criteria : | November 5, 2020 |
| First Posted : | November 10, 2020 |
| Last Update Submitted that Met QC Criteria : | October 3, 2023 |
| Last Update Posted : | October 5, 2023 |